Broadway Financial is a bank holding company based in Los Angeles, operating through City First Bank, which serves low-to-moderate income communities in Southern California and Washington, D.C. The bank provides various loan and deposit products, including mortgage and commercial loans, savings accounts, and certificates of deposit.
Based on our analysis, Broadway Financial has been assigned an overvalued rating of 1 out of 5 stars. Several key financial ratios indicate that the company is not performing favorably compared to its sector, which raises concerns about its valuation.
The Price-to-Earnings (PE) Ratio for Broadway Financial is 22.45, significantly higher than the sector average of 13.20. A high PE ratio suggests that investors are paying more for each unit of earnings, potentially indicating overvaluation or expectations of future growth that may not be met.
Furthermore, Broadway Financial's Return on Equity (ROE) is only 1.60%, compared to the sector average of 8.04%. A low ROE indicates that the company is generating less profit from its equity, which may raise questions about its efficiency and operational effectiveness.
Additionally, the Dividend Yield for Broadway Financial stands at 0.11%, far below the sector average of 2.79%. A lower dividend yield may suggest that the company is not returning sufficient value to shareholders, which could discourage potential investors looking for income generation.
Lastly, the Return on Assets (ROA) ratio is 0.33%, while the sector average is 0.84%. A low ROA signifies that the company is less effective in utilizing its assets to generate profit.
These financial metrics collectively suggest that Broadway Financial is not performing at a level that justifies its current valuation, leading to its overvalued rating.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Financials
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!